Document is current
Any future updates will be listed below
-
Authors
Lietzau, Grazyna
Davidsson, William
Östenson, Claes-Göran
Chiazza, Fausto
Nathanson, David
Pintana, Hiranya
Skogsberg, Josefin
Klein, Thomas
Nyström, Thomas
Darsalia, Vladimer
Patrone, Cesare https://orcid.org/0000-0003-0470-4606
-
Funding
Funding for this research was provided by:
O. E. och Edla Johanssons Vetenskapliga Stiftelse
STROKE-Riksförbundet
Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse
Diabetesfonden
Hjärt-Lungfonden
Novo Nordisk
Åhlén-stiftelsen
ALF Sweden
-
More Information
Article History
Received: 12 February 2018
Accepted: 12 February 2018
First Online: 23 February 2018
Ethics approval
: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.
: Work in our laboratory is supported by Boehringer Ingelheim Pharma GmbH & Co. Thomas Klein and Josefin Skogsberg are employees of Boehringer Ingelheim AB, Sweden and Boehringer Ingelheim Pharma GmbH & Co, respectiviely. Thomas Nyström has received unrestricted grants from AstraZenca and consultancy fees from Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Merck and Sanofi-Aventis.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
